Cite
HARVARD Citation
Schneider, B. et al. (2019). Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer. CPT: pharmacometrics & systems pharmacology. pp. 577-586. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schneider, B. et al. (2019). Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer. CPT: pharmacometrics & systems pharmacology. pp. 577-586. [Online].